Assessment of Cardiovascular Disease Risk
Assessment of Cardiovascular Disease Risk
复制标题
DOI：
10.1016/j.ecl.2022.02.005
复制
发表时间：
2022-09-01
影响因子：
4.5
通讯作者：
Blaha, Michael J.
中科院分区：
文献类型：
--
作者：
Goldsborough III, Earl;Osuji, Ngozi;Blaha, Michael J.
心血管疾病（CVD）是全球死亡的主要原因，动脉粥样硬化性心血管疾病（ASCVD）是CVD总死亡率的主要原因。1 -3从1993年到2019年，CVD的全球患病率几乎翻了一番4，预计到2024年将继续增加。5在美国（US），ASCVD是发病率和医疗保健支出的主要原因。6由于
Cardiovascular diseases (CVDs) are the leading cause of death worldwide, with atherosclerotic cardiovascular disease (ASCVD) being the dominant cause of total CVD mortality.1-3 From 1993 to 2019, the global prevalence of CVD nearly doubled4 and is projected to continue increasing through 2024.5 In the United States (US), ASCVD is the predominant cause of morbidity and health care expenditure.6 As